Research & Development

“We aim to develop novel Animal Vaccines by leveraging our exceptional scientific talent pool and developmental capabilities”. -Dr. Krishna M Ella

Biovet’s R&D division is engaged in the development of products and processes, and in transferring the technologies to the production section. The focus is on infectious emerging and reemerging diseases of animals with the aim to bring out economical products in the health care segment. From a one-product company Biovet has growing to a multi-product company because of its in-house R&D and process development. Scientists from various disciplines such as microbiology, biotechnology, and biochemistry work on novel and conventional technologies to develop vaccines, diagnostics, monoclonal antibodies and biologicals.

Collaborations with national and international organizations help to bring in the latest concepts and methods in product development. Scientists working in various projects interact and complement each other’s technical knowledge and skills. This provides a vibrant atmosphere for innovation and improvement.

Scientists from various disciplines such as microbiology, biotechnology, and biochemistry work on novel and conventional technologies to develop vaccines, diagnostics, monoclonal antibodies and biologicals.

Collaborations with national and international organizations help to bring in the latest concepts and methods in product development.

Scientists working in various projects interact and complement each other’s technical knowledge and skills. This provides a vibrant atmosphere for innovation and improvement. Biovet has research collaborations with several reputed national and international institutes including:

Biovet Private Ltd., partners some of the world’s finest Institutions and organizations.